BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6158737)

  • 21. Does hydroxyethyl starch cause lichen planus? Lichen planus in a long-time routine blood donor never exposed to hydroxyethyl starch.
    Newman RS; Barr RJ; Ocariz JA; Kaplan HS
    Transfusion; 1983; 23(6):531-2. PubMed ID: 6196884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of 6% hydroxyethyl starch 450/0.7, 10% dextran 40 and 3.5% gelatin on plasma volume in patients with terminal renal failure (author's transl)].
    Köhler H; Kirch W; Klein H; Distler A
    Anaesthesist; 1978 Sep; 27(9):421-6. PubMed ID: 82409
    [No Abstract]   [Full Text] [Related]  

  • 23. [Anaphylactoid reaction in rats after administration of dextran and hydroxyethyl starch manufactured in Czechoslovakia (author's transl)].
    Skala E; Pospísil J; Tachecí O
    Cas Lek Cesk; 1980 Oct; 119(40-41):1098-100. PubMed ID: 6169436
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of modern plasma expanders and blood substitutes.
    Rudowski WJ
    Br J Hosp Med; 1980; 23(4):389-99. PubMed ID: 6155961
    [No Abstract]   [Full Text] [Related]  

  • 25. An experimental study on the effect of plasma expanders on blood coagulability.
    Narita T; Matsumoto I; Kumazawa T; Ikezono E
    Bull Tokyo Med Dent Univ; 1979 Mar; 26(1):25-32. PubMed ID: 85502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Determination of the plasma elimination of hydroxyethyl starch and dextran using improved analytical methods].
    Förster H; Wicarkzyk C; Dudziak R
    Infusionsther Klin Ernahr; 1981 Apr; 8(2):88-94. PubMed ID: 6164643
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparable studies of the behaviour of the plasmic coagulation, the fibrinolysis as well as the platelets under application of dextran or hydroxyethyl-starch (HES).
    Popov-Cenić S; Müller N; Kladetzky RG; Hack G; Lang U
    Bibl Anat; 1977; (16 Pt 2):322-5. PubMed ID: 75005
    [No Abstract]   [Full Text] [Related]  

  • 28. Improved method for the cryopreservation of human red cells in liquid nitrogen with hydroxyethyl starch.
    Lionetti FJ; Hunt SM; Lin PS
    Cryobiology; 1976 Oct; 13(5):489-99. PubMed ID: 61833
    [No Abstract]   [Full Text] [Related]  

  • 29. Hydroxyethyl starch in CABG.
    Diehl JT
    Ann Thorac Surg; 1985 Jan; 39(1):97-8. PubMed ID: 2578278
    [No Abstract]   [Full Text] [Related]  

  • 30. The elimination of hydroxyethyl starch from the blood donors experiencing single of multiple intermittent-flow centrifugation leukapheresis.
    Maguire LC; Strauss RG; Koepke JA; Bowman RJ; Zelenski KR; Lambert RM; Hulse JD; Atnip AK
    Transfusion; 1981; 21(3):347-53. PubMed ID: 6165109
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experimental studies on hydroxyethyl starch as a diluent for artificial heart lung machine performance (author's transl)].
    Chu CC
    Taiwan Yi Xue Hui Za Zhi; 1979 Sep; 78(9):784-8. PubMed ID: 92526
    [No Abstract]   [Full Text] [Related]  

  • 32. [Concerning the contribution by F. Jesch, G. Hübner, V. Zumtobel, M. Zimmermann and K. Messmer, hydroxyethyl starch (HAS 450/0,7) in plasma and liver--course of concentration and human histologic changes [Infusionstherapie 6:112-117 (1979)].
    Thompson WL
    Infusionsther Klin Ernahr; 1979 Aug; 6(4):262-3. PubMed ID: 90652
    [No Abstract]   [Full Text] [Related]  

  • 33. The successful cryopreservation of microfilariae with hydroxyethyl starch as cryoprotectant.
    Minjas JN; Townson H
    Ann Trop Med Parasitol; 1980 Oct; 74(5):571-3. PubMed ID: 6162427
    [No Abstract]   [Full Text] [Related]  

  • 34. [The influence of hydroxyethyl starch on blood clotting (author's transl)].
    Peter K; Gander HP; Lutz H; Nold W; Stosiek U
    Anaesthesist; 1975 May; 24(5):219-24. PubMed ID: 56903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retarded elimination of a high-molecular enzyme-substrate-complex after hydroxyethyl-starch-infusion.
    Kirch W; Köhler H; Horstmann HJ
    Arch Toxicol Suppl; 1978; (1):335-8. PubMed ID: 79408
    [No Abstract]   [Full Text] [Related]  

  • 36. [Physico-chemical and biological properties of a chemically modified globin from bovine blood].
    Gudzhabidze MV; Tkeshelashvili TV; Rozenberg GIa; Shlimak VM; Gachechiladze KN
    Gematol Transfuziol; 1988 May; 33(5):32-4. PubMed ID: 3410265
    [No Abstract]   [Full Text] [Related]  

  • 37. [Retrospective consideration of the incidence of anaphylactoid reactions following administration of Plasmasteril and Longasteril].
    Beez M; Dietl H
    Infusionsther Klin Ernahr; 1979; 6(1):23-6. PubMed ID: 84790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The influence of the plasmaexpander hydroxyethyl starch on the serological blood grouping tests as compared to dextran 60 and whole blood (author's transl)].
    Kleine N
    Anaesthesist; 1975 May; 24(5):225-7. PubMed ID: 56904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood substitutes: two ways to get there.
    Cowart VS
    JAMA; 1983 Jan; 249(2):159, 163-4. PubMed ID: 6848791
    [No Abstract]   [Full Text] [Related]  

  • 40. Large unit red cell cryopreservation with hydroxyethyl starch.
    Allen ED; Weatherbee L; Spencer HH; Lindenauer SM; Permoad PA
    Cryobiology; 1976 Oct; 13(5):500-6. PubMed ID: 61834
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.